Answers are grounded in this paper and cite their sources.
Evaluates the protective effects of hesperidin on neurotoxicity in Drosophila, suggesting potential therapeutic benefits.
Neurodegenerative disorders are closely associated with oxidative stress, mitochondrial dysfunction, and apoptosis. Rotenone, a potent inhibitor of mitochondrial complex I, is widely used to model Parkinson-like pathology because it induces oxidative damage and selective loss of dopaminergic neurons. In the present study, Drosophila melanogaster was employed to investigate rotenone-induced neurotoxicity and to evaluate the protective potential of hesperidin, a naturally occurring flavonoid known for its antioxidant and anti-apoptotic activities. Exposure to rotenone resulted in reduced survival rates, impaired locomotion and climbing ability, elevated reactive oxygen species (ROS) levels, increased protein oxidation, and heightened caspase-3 activity, reflecting neurodegenerative changes. Notably, co-treatment with hesperidin mitigated these adverse effects by enhancing motor performance, decreasing oxidative stress markers, and suppressing apoptotic signaling. Collectively, these findings suggest that hesperidin offers significant protection against rotenone-induced neurotoxicity in D. melanogaster, highlighting its potential as a therapeutic candidate for neurodegenerative disorders.
No takes yet. Share an insight, caveat, or question.
Subhan et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: